In a press release (July 17, 2013), Scripps Research Institute scientists say that they have analyzed the three-dimensional atomic structure of the human glucagon receptor. Found mainly in cells in the liver and kidneys, the receptor helps regulate glucose levels in the blood stream. This discovery could help with the development of new drugs, which is good news for those who live with type II diabetes.
"Understanding how the glucagon receptor interacts and binds with its partners will provide new information on how cells maintain sugar levels, possibly aiding the development of treatment for glucose-related disorders", said Jean Chin, PhD, of the National Institutes of Health's National Institute of General Medical Science. The NIH partially funded this study.
The glucagon receptor is a member of a family of receptors in the human body, according to Professor Raymond C. Stevens. He is the senior author of the study. He states that this is a collaboration of researchers in the United States, China and Europe. The study will be reported in an online article of the journal Nature.
For the complete press release, go to: http://www.scripps.edu/news/press/2013/20130717stevens.html
No comments:
Post a Comment